<DOC>
	<DOCNO>NCT02945059</DOCNO>
	<brief_summary>The aim study prospectively evaluate tolerance efficiency new technique preoperative selective portal vein embolization ( PVE ) patient require major hepatic resection .</brief_summary>
	<brief_title>Reversible Portal Vein Embolization Before Major Hepatectomy</brief_title>
	<detailed_description>Portal vein embolization ( PVE ) use major hepatectomy induce hypertrophy future liver remnant ( FLR ) . A non-reversible absorbable material generally use embolization , provide effective , permanent vascular occlusion . Our team develop minimally invasive technique reversible PVE use gelfoam powder . The aim study assess tolerance efficiency preoperative reversible selective PVE patient require major hepatic resection . We hypothesize preoperative reversible PVE allow similarly increase FLR volume comparison classical non-reversible PVE patient require major liver resection limit FLR . The hypertrophy ratio classical non-reversible PVE evaluate literature 13 % . We estimate hypertrophy ratio reversible PVE 9 % previous retrospective study . The aim pilot study prospectively evaluate hypertrophy ratio reversible PVE . Primary End Point : Hypertrophy ratio FLR volume / total liver volume baseline PVE , assess compute tomography scan volumetry 4-6 week PVE .</detailed_description>
	<criteria>Patient age 18 80 year Patient require major liver resection ( least 3 segment ) PVE indication decide multidisciplinary meeting Patients able understand follow instruction able participate study entire period Patients must give write informed consent participate study receive adequate previous information prior studyspecific procedure Patient affiliate French National Social Security System American Score Anesthesiologist ( ASA ) ≥ 3 Portal vein hepatic vein thrombosis Associated ( 6 week PVE ) percutaneous liver treatment Patient cover social security service Patient guardianship Participation another clinical trial precede 3 month . Patients medical disorder , condition , history would impair patient 's ability participate complete study opinion investigator . Patients already anaphylactic anaphylactoid reaction injection iodinate contrast medium ( edema Quincke… ) Patients allergy pork product</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Liver regeneration</keyword>
	<keyword>portal vein embolization</keyword>
	<keyword>gelatin powder</keyword>
	<keyword>liver surgery</keyword>
	<keyword>hepatectomy</keyword>
</DOC>